Find a Doctor

Dr. Christoph Schramm

University Medical Center Hamburg Eppendorf

Bio


Dr. Schramm is a global expert in Sclerosing Cholangitis. He has been an author on 219 peer reviewed articles in the past 15 years. In particular, he has been an author on 71 peer reviewed articles regarding Sclerosing Cholangitis.

Contact

DE

Latest Advances


  • Condition: Primary Biliary Cholangitis (PBC)
  • Journal: Journal of hepatology
  • Treatment Used: Preventative Ursodeoxycholic Acid (UDCA) after Transplantation
  • Number of Patients: 780
  • Published —
This study tested the safety and efficacy of using UDCA after transplantation to treat patients with PBC.
  • Condition: Autoimmune Hepatitis (AIH)
  • Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • Treatment Used: Liver Transplantation (LT)
  • Number of Patients: 30970
  • Published —
This study analyzed long-term patient and graft survival after liver transplantation for autoimmune hepatitis (AIH-LT).
  • Condition: Primary Sclerosing Cholangitis (PSC)
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Tumor Necrosis Factor (TNF) Antagonists
  • Number of Patients: 141
  • Published —
This study evaluated the effects of tumor necrosis factor (TNF) antagonists (medicines that suppress the body's natural response to tumor necrosis factor, a protein produced by white blood cells that is involved in early inflammatory events) in patients with primary sclerosing cholangitis (chronic disease in which the bile ducts inside and outside the liver become inflamed and scarred, and eventually narrowed or blocked; PSC).
  • Condition: Autoimmune Hepatitis (AIH)
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Rapid Response to Treatment
  • Number of Patients: 740
  • Published —
This study assessed he outcomes of patients with vs without rapid response to treatment of autoimmune hepatitis (AIH) in a large international cohort.
  • Condition: Autoimmune Hepatitis
  • Journal: United European gastroenterology journal
  • Treatment Used: Steroid Induction Therapy Followed by Maintenance Therapy with Azathioprine, Second-Line Treatment with Other Immunosuppressants
  • Number of Patients: 0
  • Published —
This article discusses the treatment of autoimmune hepatitis, a rare and chronic liver disease that is characterized by increased serum transaminases and immunoglobulin G, inflammatory liver histology and presence of circulating autoantibodies.
  • Condition: Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Vedolizumab
  • Number of Patients: 102
  • Published —
The study researched the outcomes of Vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases.
  • Condition: Bloodstream Infection in Patients With Liver Cirrhosis
  • Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Treatment Used: Extended Infusion of ?-Lactams
  • Number of Patients: 312
  • Published —
The study researched the outcomes of extended infusion of ?-Lactams for bloodstream Infection in patients with liver cirrhosis.

Clinical Trials


Contact

DE

Insurance

Contact them to find out if they accept your insurance plan.